Pharmagreen Biotech, Inc. Strategic Relationship with Alliance Growers Inc.
2018年7月26日 - 8:00PM
Pharmagreen Biotech, Inc. (f/k/a Air Transport Group Holdings,
Inc.), (OTC PINKS: AITGD), a cannabis biotech company focused
on producing cannabis starter plantlets through its proprietary
tissue culture process is pleased to announce that its wholly owned
Canadian subsidiary, WFS Pharmagreen Inc., is currently completing
its pre-construction phase of its 62,000 square foot cannabis
biotech complex. WFS Pharmagreen has filed for regulatory approval
from Health Canada for the cannabis biotech complex. The facility
will supply over ten million cannabis tissue culture starter
plantlets on an annual basis, operating at full capacity. The
company’s plan is reach over ninety percent of production capacity
in the first year. Ten million starter plantlets produced at an
average sale price of $8 US per plantlet would generate eighty
million US dollars in annual gross revenues.
The company is working closely with its strategic investment
partner, Alliance Growers Inc., publicly traded on the Canadian
Stock Exchange under (CSE: ACG), and on the Frankfurt Stock
exchange under the symbol (1LA). Alliance Growers has the
opportunity to own up to 30% equity interest in Pharmagreen’s
Cannabis Biotech Complex in Deroche, B.C., Canada. To date
the funds invested by Alliance Growers have been put towards
pre-construction phase of the project.
Alliance Growers business model integrates well with
Pharmagreen’s business plan. Alliance Growers focus is on the
development, acquisition of early stage cannabis grow companies and
establishing retail stores via the acquisition of Spyder Vapes Inc.
and/or other similar outlets across Canada. Pharmagreen
Biotech will benefit from this relationship with supply contracts
for its tissue culture plantlets and for the distribution and sale
of Pharmagreen branded medical cannabis products.
CEO of Alliance, Dennis Petke stated,” When we were introduced
to the Tissue Culture Plantlet business by Peter Wojcik, that
changed everything for Alliance. Once we were fully educated on the
technology and we fully embraced Mr. Wojcik’s vision, it was clear
that the services to be made available through the cannabis biotech
complex were going to be a significant improvement to the growing
quality and improved bottom line for all growers who have access to
such supply across Canada and
internationally.”
Commenting on the relationship with Alliance Growers,
Pharmagreen’s, President and CEO, Peter Wojcik, stated “Working
with Dennis Petke, who is of the same vision and with a
focused business strategy to get the cannabis biotech complex
construction moving ahead with Pharmagreen and unilaterally looking
to secure supply contracts and retail shelf space, this model works
well.”
About Alliance Growers Corp.
Alliance Growers is a diversified cannabis company driven by the
Company’s ‘Four Pillars’ Organization Plan – Cannabis Biotech
Complex, Strategic ACMPR Investments, CBD Oil Supply and
Distribution, and Research and Technology. For more information on
Alliance Growers Inc. please visit www.alliancegrowers.com
About Pharmagreen Biotech, Inc. and WFS Pharmagreen
Inc.
WFS Pharmagreen Inc. is a wholly owned Canadian based subsidiary
of Pharmagreen Biotech, Inc., a publicly traded (OTC PINKS: AITGD)
company. WFS Pharmagreen Inc. is a cannabis company that is
becoming the largest producer of cannabis plantlets through a
proprietary tissue culture process with opportunity to become one
of the largest players globally. Pharmagreen’s mission is to
advance the technology of tissue culture science and to provide the
highest quality 100% germ free, disease free and all genetically
the same plantlets of cannabis and other flora while offering full
spectrum DNA testing for plant identification, live genetics
preservation using low temperature storage for various
cannabis and horticulture plants; extraction of botanical oils
mainly CBD oil, and to deliver laboratory based services to the
North American Cannabis and agriculture sectors. For further
information on the company progress on the construction of a 62,000
square foot “Cannabis Biotech Complex” please
visit www.pharmagreen.ca
Safe Harbor Statement
This press release contains forward-looking statements. Such
forward-looking statements are subject to a number of risks,
assumptions and uncertainties that could cause the Company's actual
results to differ materially from those projected in such
forward-looking statements. In particular, factors that could cause
actual results to differ materially from those in forward looking
statements include: our inability to obtain additional financing on
acceptable terms; risk that our products and services will not gain
widespread market acceptance; inability to compete with others who
provide comparable products; the failure of our technology; the
infringement of our technology with proprietary rights of third
parties; inability to respond to consumer demands; inability to
replace significant customers; seasonal nature of our business.
Forward-looking statements speak only as of the date made and are
not guarantees of future performance. We undertake no obligation to
publicly update or revise any forward-looking statements. When used
in this document, the words "believe," "expect," "anticipate,"
"estimate," "project," "plan," "should," "intend," "may," "will,"
"would," "potential," and similar expressions may be used to
identify forward-looking statements.
The OTC Markets or any other securities regulatory authority has
not reviewed and does not accept responsibility for the adequacy or
accuracy of this press release that has been prepared by
management.
Contact Information:
Tel: (702) 803 9404
Email: info@pharmagreen.ca
Alliance Growers (CSE:ACG)
過去 株価チャート
から 10 2024 まで 10 2024
Alliance Growers (CSE:ACG)
過去 株価チャート
から 10 2023 まで 10 2024